Krishnan Subharaman

Krishnan Subharaman

Active Director Director DIN 01518995
DIN 01518995 First appointment Jul 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 10 historical roles
Total affiliations 11 Since Jul 2007
Shareholding value •••• Premium profile

About Krishnan Subharaman

Data last updated:

Krishnan Subharaman is a Director at Jenburkt Pharmaceuticals Ltd (since 2024). The companies operate in Pharma, Engineering and Business Services. Jenburkt Pharmaceuticals Ltd reported revenue of ₹158 Cr (FY 2025). Earlier, Krishnan Subharaman was a Company Secretary at Unichem Laboratories Limited (2008–2015) and Director at Ishanya Realty Corporation Limited (2018–2022) and 8 more.

DIN 01518995
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2007
Oldest Company Age 41 yrs
Largest company Jenburkt Pharmaceuticals Ltd · ₹158 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jenburkt Pharmaceuticals Ltd L24230MH1985PLC036541
Director28 May 20241985₹158 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unichem Laboratories Limited L99999MH1962PLC012451
Company Secretary18 Jan 20081962₹2,146 Cr (FY 2025)Active
Ishanya Realty Corporation Limited U70101PN2008PLC131330
Director20 Aug 20182008Active
Ishanya Brand Services Limited U74900PN2008PLC131967
Director20 Aug 20182008₹5.22 Cr (FY 2025)Active
Ethnor Consumer Health Care Limited U24230MH2007PLC172131
Director05 Jul 20072007Strike Off
Nodal Officer12 Aug 20161979₹11,609 Cr (FY 2026)Active
Deepak Agro Solutions Limited U24129MH1996PLC099312
Director20 Aug 20181996₹15.7 Lakh (FY 2022)Amalgamated
Scm Fertichem Limited U24211PN2012PLC145023
Director20 Aug 20182012₹1.06 Cr (FY 2023)Active
Sundrop Brands Limited L15142TG1986PLC006957
Company Secretary16 Oct 20071986₹901 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Krishnan Subharaman

Directorship timeline

Open interactive timeline →
Jenburkt Pharmaceuticals Ltd
Unichem Laboratories Limited
Ishanya Realty Corporation Limited
Ishanya Brand Services Limited
Premium access

Shareholding and investment profile for Krishnan Subharaman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnan Subharaman

Krishnan Subharaman currently holds 1 directorship: Jenburkt Pharmaceuticals Ltd (Director, since 28 May 2024, revenue ₹158 Cr (FY 2025)).

Krishnan Subharaman was first appointed on 05 Jul 2007 as Director at Ethnor Consumer Health Care Limited. The most recent appointment on record is 28 May 2024 at Jenburkt Pharmaceuticals Ltd.

Krishnan Subharaman held 10 earlier board appointments: Unichem Laboratories Limited (Company Secretary, 18 Jan 2008 to 18 May 2015); Ishanya Realty Corporation Limited (Director, 20 Aug 2018 to 23 Mar 2022); Ishanya Brand Services Limited (Director, 20 Aug 2018 to 23 Mar 2022); Ethnor Consumer Health Care Limited (Director, 05 Jul 2007 to 01 Sep 2007); Deepak Fertilisers And Petrochemicals Corporation Ltd (Nodal Officer, 12 Aug 2016 to 25 Nov 2020); and 5 more.

The current boards of Krishnan Subharaman's companies include Ashish Rasiklal Shah (Jenburkt Pharmaceuticals Ltd), Ashish Uttam Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Dilip Harkishandas Bhuta (Jenburkt Pharmaceuticals Ltd), Hina Ravindra Mehta (Jenburkt Pharmaceuticals Ltd), Pankaj Arun Dantwala (Jenburkt Pharmaceuticals Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available